Merck & Co Inc (NYSE:MRK)
| 82.54 Delayed Data As of 4:19pm ET |  -0.39 / -0.47%Today’s Change | 65.25 Today|||52-Week Range 92.64 | -9.25% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 82.93 |
| Today’s open | 83.03 |
| Day’s range | 82.54 - 83.70 |
| Volume | 5,840,705 |
| Average volume (3 months) | 8,917,924 |
| Market cap | $209.7B |
Data as of 4:19pm ET, 09/28/2020
Growth & Valuation
| Earnings growth (last year) | +64.36% |
| Earnings growth (this year) | +10.16% |
| Earnings growth (next 5 years) | +7.25% |
| Revenue growth (last year) | +9.75% |
| P/E ratio | 20.2 |
| Price/Sales | 5.04 |
| Price/Book | 8.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.71 | +1.97% |
| NVSNovartis | -0.06 | -0.07% |
| ABBVAbbVie | +1.06 | +1.23% |
| AZNAstraZeneca | -0.82 | -1.48% |
Data as of 5:17pm ET, 09/28/2020
Financials
| Next reporting date | October 27, 2020 |
| EPS forecast (this quarter) | $1.43 |
| Annual revenue (last year) | $46.6B |
| Annual profit (last year) | $9.8B |
| Net profit margin | 21.13% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
